Furthermore, the expression level of SNHG14 in circulating EVs was increased in patients who exhibited resistance to trastuzumab, compared with those exhibiting a response, suggesting lncRNA-SNHG14 in serum vesicles as a potential diagnostic biomarker for breast cancer [84]. Here, SNHG14 is linked to breast carcinoma.